Enhanced collaboration between hospital and community pharmacists for better post-hospital care
Zusammenfassung der Studie
For patients taking multiple medications, hospitalization often involves changes in treatment. Upon discharge, the lack of communication between the hospital and the community pharmacy can make discharge prescriptions complex and lead to medication-related issues. Without all the necessary information, pharmacies may not always ensure optimal dispensing of medications, which can compromise their effectiveness and safety. We aim to evaluate the benefits of this collaboration for adult patients hospitalized in internal medicine at a regional hospital, who are taking seven or more medications and are returning home after their hospitalization. This study seeks to answer the following question: does enhanced collaboration reduce the number of medication-related problems encountered by community pharmacists when dispensing discharge prescriptions? To do this, we will compare two situations: when the hospital pharmacist is involved in the discharge process and when they are not, which corresponds to the usual care. The hospital pharmacist will not interact directly with the patient but will collaborate with the community pharmacy. To participate, patients will need to go to their usual pharmacy or ask a relative to do so if necessary. Once the medications are received after their hospital discharge, participants will be invited to complete a satisfaction questionnaire.
(BASEC)
Untersuchte Intervention
Enhanced collaboration and information transfer between hospital and community pharmacists during hospital discharge.
(BASEC)
Untersuchte Krankheit(en)
Polypharmacy
(BASEC)
- Patients admitted to the internal medicine department for more than 48 hours - Patients returning home after hospital discharge - Patients taking 7 or more medications at the time of inclusion - Patients able to give informed consent (BASEC)
Ausschlusskriterien
- Patients not returning home after hospital discharge (transfer to another hospital, clinic, or medical-social establishment) - Patients whose hospital discharge prescription contains fewer than 7 medications - Patients who do not wish to choose another pharmacy if their usual pharmacy has not agreed to participate in the study - Inability to sign consent and follow the study procedures due to language issues, psychological disorders, dementia, altered consciousness, and lack of discernment (BASEC)
Studienstandort
Andere
(BASEC)
Rennaz
(BASEC)
Sponsor
Pharmacie des Hôpitaux de l'Est Lémanique
(BASEC)
Kontakt für weitere Auskünfte zur Studie
Kontaktperson Schweiz
Paul Garin
+41795342136
paul.garin@clutterphel.chPharmacie des Hôpitaux de l'Est Lémanique
(BASEC)
Allgemeine Auskünfte
Pharmacie des Hpitaux de l'Est Lmanique
+41 79 534 21 36+41 79 534 21 36
paul.garin@clutterphel.ch(ICTRP)
Name der bewilligenden Ethikkommission (bei multizentrischen Studien nur die Leitkommission)
Ethikkommission Waadt
(BASEC)
Datum der Bewilligung durch die Ethikkommission
10.07.2025
(BASEC)
ICTRP Studien-ID
NCT06902779 (ICTRP)
Offizieller Titel (Genehmigt von der Ethikkommission)
Enhanced collaboration between hospital and community pharmacists to improve the hospital discharge process (BASEC)
Wissenschaftlicher Titel
Enhanced Collaboration Between Hospital and Community Pharmacists to Improve the Hospital Discharge Process (ICTRP)
Öffentlicher Titel
Evaluation of the Impact of a Collaboration Between Hospital and Community Pharmacists At Hospital Discharge (ICTRP)
Untersuchte Krankheit(en)
Polypharmacy (ICTRP)
Untersuchte Intervention
Other: Support of the hospital pharmacist for the medication management at hospital discharge (ICTRP)
Studientyp
Interventional (ICTRP)
Studiendesign
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: None (Open Label). (ICTRP)
Ein-/Ausschlusskriterien
Inclusion Criteria:
- Patients admitted to the internal medicine ward for more than 48 hours
- Patients prescribed seven or more drugs at the time of screening
- Patients discharged to home
- Patients able to give informed consent as documented by signature
Exclusion Criteria:
- Patient discharged to another hospital, nursing home or rehabilitation clinic
- Refusal of the community pharmacy to participate
- Inability to sign consent and follow the procedures of the study, due to language
problems, psychological disorders, dementia, alterations of consciousness and lack
of judgement (ICTRP)
nicht verfügbar
Primäre und sekundäre Endpunkte
Number of drug-related problems on the hospital discharge prescription (ICTRP)
Patient's satisfaction;Community pharmacists' satisfaction;30 day readmission rate (ICTRP)
Registrierungsdatum
nicht verfügbar
Einschluss des ersten Teilnehmers
nicht verfügbar
Sekundäre Sponsoren
nicht verfügbar
Weitere Kontakte
Anne-Laure Blanc, PharmD, PhDPaul Garin, PharmDPaul Garin, PharmD, paul.garin@phel.chpaul.garin@phel.ch, +41 79 534 21 36+41 79 534 21 36, Pharmacie des Hpitaux de l'Est Lmanique (ICTRP)
Sekundäre IDs
ECHOPHARM (ICTRP)
Angaben zur Verfügbarkeit von individuellen Teilnehmerdaten
nicht verfügbar
Weitere Informationen zur Studie
https://clinicaltrials.gov/ct2/show/NCT06902779 (ICTRP)
Ergebnisse der Studie
Zusammenfassung der Ergebnisse
nicht verfügbar
Link zu den Ergebnissen im Primärregister
nicht verfügbar